The measurement of thrombin in clotting blood by radioimmunoassay.

We have developed a radioimmunoassay for human thrombin using rabbit anti-human thrombin IgG. The assay can measure 2 ng thrombin/ml plasma, 500-fold more sensitive than clotting assays. Human prothrombin is less reactive in the assay than thrombin by at least four orders of magnitude, and there is no demonstrable cross-reactivity with human factor Xa, the clotting factor structurally most similar to thrombin. The assay does not detect thrombin bound to anthithrombin III. Using the assay, we have demonstrated that plasma from 20 normal subjects does not contain detectable thrombin. We measured thrombin generation in clotting blood in polypropylene tubes and observed that thrombin appears (approximately equal to 3 ng/ml) within 45 S-5 min after venipuncture. This material is thrombin, not intermediates of prothrombin activation, since it disappears after addition of heparin, which promotes thrombin antithrombin III complex formation. After a plateau of 2-10 min, there is further thrombin generation, which results in clotting after 15-27 min at a level of 40-50 ng thrombin/ml. The thrombin generated 9-25 min before clotting may activate factors V and VIII and stimulate platelet aggregation and release. In contrast, the cascade hypothesis assigns a role for thrombin only late in blood clotting. Radioimmunoassay of thrombin and other clotting factors will be useful for clinical and physiological studies of blood clotting especially since the assay seems specific for thrombin and is independent of other activities that affect bioassays.

[1]  S. Rapaport,et al.  The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity. , 1963, Blood.

[2]  K. Kurachi,et al.  Characterization of human, bovine, and horse antithrombin III. , 1976, Biochemistry.

[3]  K. Mann,et al.  The activation of prothrombin. II. Partial reactions, physical and chemical characterization of the intermediates of activation. , 1973, The Journal of biological chemistry.

[4]  P. Cuatrecasas,et al.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography. , 1974, Analytical biochemistry.

[5]  K. Fujikawa,et al.  A comparison of bovine prothrombin, factor IX (Christmas factor), and factor X (Stuart factor). , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. Blout,et al.  Mechanism of bovine prothrombin activation by an insoluble preparation of bovine factor X a (thrombokinase). , 1972, Biochemistry.

[7]  R. Colman.  The effect of proteolytic enzymes on bovine factor V. I. Kinetics of activation and inactivation by bovine thrombin. , 1969, Biochemistry.

[8]  H. Bohn.  COMPARATIVE STUDIES ON THE FIBRIN‐STABILIZING FACTORS FROM HUMAN PLASMA, PLATELETS AND PLACENTAS * , 1972, Annals of the New York Academy of Sciences.

[9]  W. Seegers,et al.  FACTORS WHICH INFLUENCE THE ACTIVITY OF PURIFIED THROMBIN , 1942 .

[10]  E. Shaw,et al.  The Purification of Thrombin and Isolation of a Peptide Containing the Active Center Histidine , 1971 .

[11]  F. Duckert,et al.  The Stuart-Prower Factor Assay and its Clinical Significance , 1958, Thrombosis and Haemostasis.

[12]  H. Prydz.  STUDIES ON PROCONVERTIN (FACTOR VII). VI. THE PRODUCTION IN RABBITS OF AN ANTISERUM AGAINST FACTOR VII. , 1965, Scandinavian journal of clinical and laboratory investigation.

[13]  E. T. Yin,et al.  Heparin interaction with activiated factor X and its inhibitor. , 1975, Advances in experimental medicine and biology.

[14]  K. Mann,et al.  Human prothrombin activation. , 1975, The Journal of biological chemistry.

[15]  R. Rosenberg,et al.  The purification and mechanism of action of human antithrombin-heparin cofactor. , 1973, The Journal of biological chemistry.

[16]  K. Denson,et al.  The Use of Antibodies in the Study of Blood Coagulation. , 1968 .

[17]  D. Baughman.  [9] Thrombin assay , 1970 .

[18]  Y. Nemerson,et al.  The control of prothrombin conversion. Kinetic control by mechanisms inherent in two activation pathways. , 1975, Biochemistry.

[19]  R. Wagner,et al.  A Simple Method for Preparing Fibrinogen , 1966, Thrombosis and Haemostasis.

[20]  L. Hoyer.  Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen. , 1972, The Journal of laboratory and clinical medicine.

[21]  K. Mann,et al.  Multiple active forms of thrombin. II. Mechanism of production from prothrombin. , 1971, The Journal of biological chemistry.

[22]  V. P. Butler,et al.  The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity. , 1976, The Journal of clinical investigation.

[23]  E. Davie,et al.  The Isolation and Characterization of Bovine Factor VIII (Antihemophilic Factor) , 1972 .

[24]  R. Canfield,et al.  Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes. , 1975, The Journal of clinical investigation.

[25]  C. Taswell,et al.  Immunochemical relationships of the intermediates of prothrombin activation. , 1975, Immunochemistry.

[26]  D. Beeler,et al.  Activation of human prothrombin by highly purified human factors V and X-a in presence of human antithrombin. , 1975, The Journal of biological chemistry.

[27]  E. Davie,et al.  Isolation and characterization of human Factor VIII (antihemophilic factor). , 1973, The Journal of biological chemistry.

[28]  S. Shapiro.  Human Prothrombin Activation: Immunochemical Study , 1968, Science.

[29]  H. Prydz,et al.  Factor X , 1971, Thrombosis and Haemostasis.

[30]  C. Esmon,et al.  The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin. , 1974, The Journal of biological chemistry.